Access DX Laboratory in Houston, Texas, its former CEO Michael Stewart, and Florida businessman Harold Shatz have settled allegations of violating the False Claims Act by paying kickbacks and billing Medicare/Medicaid for unnecessary genetic testing. The settlement totals $36.4 million, resolving claims that from 2018-2020, the entities paid kickbacks to marketers for patient referrals, unbundled billing codes, and submitted false claims. A five-year Corporate Integrity Agreement was imposed on Access DX to strengthen compliance measures. Stewart and Shatz each pleaded guilty to conspiracy to defraud the U.S. and agreed to civil settlements. A whistleblower, Douglas Green, received $7.2 million from the total recovery. The resolution involved coordinated efforts between the Justice Department’s Civil Division, the Northern District of Georgia U.S. Attorney’s Office, and the HHS Office of Inspector General. The case highlights enforcement against healthcare fraud and the use of the False Claims Act to recover taxpayer funds.
Source: U.S. Department of Justice (DOJ).
Materials reproduced from https://www.justice.gov/.
No endorsement by the DOJ is implied.
Made by AI. If you spot anything of concern write us at contact@cybach.com. We’ll promptly correct irregularities.